Savara Inc. (SVRA) - Latest Market Data

Price & Market Data

Price: $2.19

Daily Change: -$0.14 / 6.39%

Range: $2.14 - $2.35

Market Cap: $380,241,376

Volume: 945,789

Performance Metrics

1 Week: -11.65%

1 Month: -27.15%

3 Months: -15.38%

6 Months: -40.86%

1 Year: -44.44%

YTD: -28.34%

Company Details

Employees: 59

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Selected stocks

FAST TRACK GROUP (FTRK)

Myriad Genetics, Inc. (MYGN)

Xylo Technologies Ltd. (XYLO)